CIA
MIRM icon

Concurrent Investment Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

Concurrent Investment Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$366K Buy
3,964
+964
+32% +$90.7K ﹤0.01% 1379
2025
Q4 		$237K Hold
3,000
– – ﹤0.01% 1546
2025
Q3 		$220K Buy
+3,000
New +$191K ﹤0.01% 1304

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Concurrent Investment Advisors's MIRM Position: Q1 2026 in Review

Concurrent Investment Advisors increased its Mirum Pharmaceuticals (MIRM) stake by 32% in Q1 2026, buying an estimated $90.7K and bringing the position to 3,964 shares worth $366K. The position accounts for ﹤0.01% of the portfolio, ranked #1379.

Concurrent Investment Advisors first reported a position in MIRM in Q3 2025 and has held it in 3 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Concurrent Investment Advisors held 3,964 shares of Mirum Pharmaceuticals worth $366K as of Q1 2026.
  • Concurrent Investment Advisors bought 964 Mirum Pharmaceuticals shares in Q1 2026, an estimated $90.7K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q1 2026, its #1379 holding.
  • Concurrent Investment Advisors first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.